SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-04-120268
Filing Date
2004-07-19
Accepted
2004-07-19 16:53:04
Documents
4
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.3 TO FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 2003 d10ka.htm 10-K/A 1144498
2 CERTIFICATION OF CEO dex311.htm EX-31.1 10588
3 CERTIFICATION OF CFO dex312.htm EX-31.2 10606
5 GRAPHIC g23903img1.jpg GRAPHIC 4620
  Complete submission text file 0001193125-04-120268.txt   1172224
Mailing Address
Business Address 16825 NORTHCHASE DR STE 1300 HOUSTON TX 77060 2818732674
US ONCOLOGY INC (Filer) CIK: 0000943061 (see all company filings)

IRS No.: 841213501 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-26190 | Film No.: 04920412
SIC: 8093 Services-Specialty Outpatient Facilities, NEC